0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Substance Packaging Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-24D15355
Home | Market Reports | Business & Industrial| Transportation & Logistics| Packaging
Global Infectious Substance Packaging Market Research Report 2023
BUY CHAPTERS

Global Infectious Substance Packaging Market Research Report 2025

Code: QYRE-Auto-24D15355
Report
May 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infectious Substance Packaging Market Size

The global market for Infectious Substance Packaging was valued at US$ 145 million in the year 2024 and is projected to reach a revised size of US$ 219 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Infectious Substance Packaging Market

Infectious Substance Packaging Market

Infectious substance packaging refers to the specialized packaging designed to safely transport and contain materials that are known or suspected to contain infectious agents. These packaging systems are specifically designed to prevent the spread of pathogens and protect individuals from potential exposure to harmful microorganisms during transportation.
The infectious substance packaging global market refers to the market for packaging materials and solutions specifically designed to safely transport and handle infectious substances. This includes packaging and labeling requirements set by international and national regulations such as the United Nations (UN) Recommendations on the Transport of Dangerous Goods and the International Air Transport Association (IATA) Dangerous Goods Regulations. The market for infectious substance packaging is driven by the growing need to transport and handle infectious materials safely in various industries, including healthcare, pharmaceuticals, diagnostics, research laboratories, and biotechnology. This includes transporting specimens for diagnostic testing, shipping infectious samples for research purposes, and safely disposing of or transporting medical waste. Key players in the infectious substance packaging market offer a range of products such as biohazard bags, specimen transport bags, containers, vials, absorbent materials, and labels that comply with the required regulations. These packaging solutions are designed to prevent leakage, protect against contamination, and ensure the safety of individuals handling or coming into contact with infectious substances. The market is also influenced by advancements in packaging technologies, such as the development of leak-proof and tamper-evident packaging solutions, as well as the increasing adoption of automated packaging systems that improve efficiency and ensure compliance with regulations. Geographically, the infectious substance packaging market is global in nature, with companies operating internationally to meet the demands of various industries and comply with different regulatory frameworks. The market is expected to continue growing as awareness of the importance of safe handling and transportation of infectious substances increases and as regulations become more stringent to ensure public and environmental safety.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Substance Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Substance Packaging.
The Infectious Substance Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Substance Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Substance Packaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Infectious Substance Packaging Market Report

Report Metric Details
Report Name Infectious Substance Packaging Market
Accounted market size in year US$ 145 million
Forecasted market size in 2031 US$ 219 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • UN2814
  • UN2900
  • UN3373
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Air Sea Containers, CIBESMED Ltd, ALEX BREUER GMBH, E3 Cortex, Berlin Packaging LLC, CFT Canada, ICC, Therapak™, Serpac, Friobox
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Infectious Substance Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Infectious Substance Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Infectious Substance Packaging Market growing?

Ans: The Infectious Substance Packaging Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Infectious Substance Packaging Market size in 2031?

Ans: The Infectious Substance Packaging Market size in 2031 will be US$ 219 million.

Who are the main players in the Infectious Substance Packaging Market report?

Ans: The main players in the Infectious Substance Packaging Market are Air Sea Containers, CIBESMED Ltd, ALEX BREUER GMBH, E3 Cortex, Berlin Packaging LLC, CFT Canada, ICC, Therapak™, Serpac, Friobox

What are the Application segmentation covered in the Infectious Substance Packaging Market report?

Ans: The Applications covered in the Infectious Substance Packaging Market report are Healthcare and Medical Laboratories, Pharmaceutical Industry, Veterinary Medicine, Hazardous Waste Management

What are the Type segmentation covered in the Infectious Substance Packaging Market report?

Ans: The Types covered in the Infectious Substance Packaging Market report are UN2814, UN2900, UN3373, Others

Recommended Reports

Pharma Packaging

Infectious Disease Diagnostics

Medical Packaging Materials

1 Infectious Substance Packaging Market Overview
1.1 Product Definition
1.2 Infectious Substance Packaging by Type
1.2.1 Global Infectious Substance Packaging Market Value Comparison by Type (2024 VS 2031)
1.2.2 UN2814
1.2.3 UN2900
1.2.4 UN3373
1.2.5 Others
1.3 Infectious Substance Packaging by Application
1.3.1 Global Infectious Substance Packaging Market Value by Application (2024 VS 2031)
1.3.2 Healthcare and Medical Laboratories
1.3.3 Pharmaceutical Industry
1.3.4 Veterinary Medicine
1.3.5 Hazardous Waste Management
1.4 Global Infectious Substance Packaging Market Size Estimates and Forecasts
1.4.1 Global Infectious Substance Packaging Revenue 2020-2031
1.4.2 Global Infectious Substance Packaging Sales 2020-2031
1.4.3 Global Infectious Substance Packaging Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Infectious Substance Packaging Market Competition by Manufacturers
2.1 Global Infectious Substance Packaging Sales Market Share by Manufacturers (2020-2025)
2.2 Global Infectious Substance Packaging Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Infectious Substance Packaging Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Infectious Substance Packaging, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infectious Substance Packaging, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infectious Substance Packaging, Product Type & Application
2.7 Global Key Manufacturers of Infectious Substance Packaging, Date of Enter into This Industry
2.8 Global Infectious Substance Packaging Market Competitive Situation and Trends
2.8.1 Global Infectious Substance Packaging Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Infectious Substance Packaging Players Market Share by Revenue
2.8.3 Global Infectious Substance Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Infectious Substance Packaging Market Scenario by Region
3.1 Global Infectious Substance Packaging Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Infectious Substance Packaging Sales by Region: 2020-2031
3.2.1 Global Infectious Substance Packaging Sales by Region: 2020-2025
3.2.2 Global Infectious Substance Packaging Sales by Region: 2026-2031
3.3 Global Infectious Substance Packaging Revenue by Region: 2020-2031
3.3.1 Global Infectious Substance Packaging Revenue by Region: 2020-2025
3.3.2 Global Infectious Substance Packaging Revenue by Region: 2026-2031
3.4 North America Infectious Substance Packaging Market Facts & Figures by Country
3.4.1 North America Infectious Substance Packaging Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Infectious Substance Packaging Sales by Country (2020-2031)
3.4.3 North America Infectious Substance Packaging Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Infectious Substance Packaging Market Facts & Figures by Country
3.5.1 Europe Infectious Substance Packaging Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Infectious Substance Packaging Sales by Country (2020-2031)
3.5.3 Europe Infectious Substance Packaging Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infectious Substance Packaging Market Facts & Figures by Region
3.6.1 Asia Pacific Infectious Substance Packaging Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Infectious Substance Packaging Sales by Region (2020-2031)
3.6.3 Asia Pacific Infectious Substance Packaging Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Infectious Substance Packaging Market Facts & Figures by Country
3.7.1 Latin America Infectious Substance Packaging Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Infectious Substance Packaging Sales by Country (2020-2031)
3.7.3 Latin America Infectious Substance Packaging Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Infectious Substance Packaging Market Facts & Figures by Country
3.8.1 Middle East and Africa Infectious Substance Packaging Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Infectious Substance Packaging Sales by Country (2020-2031)
3.8.3 Middle East and Africa Infectious Substance Packaging Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infectious Substance Packaging Sales by Type (2020-2031)
4.1.1 Global Infectious Substance Packaging Sales by Type (2020-2025)
4.1.2 Global Infectious Substance Packaging Sales by Type (2026-2031)
4.1.3 Global Infectious Substance Packaging Sales Market Share by Type (2020-2031)
4.2 Global Infectious Substance Packaging Revenue by Type (2020-2031)
4.2.1 Global Infectious Substance Packaging Revenue by Type (2020-2025)
4.2.2 Global Infectious Substance Packaging Revenue by Type (2026-2031)
4.2.3 Global Infectious Substance Packaging Revenue Market Share by Type (2020-2031)
4.3 Global Infectious Substance Packaging Price by Type (2020-2031)
5 Segment by Application
5.1 Global Infectious Substance Packaging Sales by Application (2020-2031)
5.1.1 Global Infectious Substance Packaging Sales by Application (2020-2025)
5.1.2 Global Infectious Substance Packaging Sales by Application (2026-2031)
5.1.3 Global Infectious Substance Packaging Sales Market Share by Application (2020-2031)
5.2 Global Infectious Substance Packaging Revenue by Application (2020-2031)
5.2.1 Global Infectious Substance Packaging Revenue by Application (2020-2025)
5.2.2 Global Infectious Substance Packaging Revenue by Application (2026-2031)
5.2.3 Global Infectious Substance Packaging Revenue Market Share by Application (2020-2031)
5.3 Global Infectious Substance Packaging Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Air Sea Containers
6.1.1 Air Sea Containers Company Information
6.1.2 Air Sea Containers Description and Business Overview
6.1.3 Air Sea Containers Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Air Sea Containers Infectious Substance Packaging Product Portfolio
6.1.5 Air Sea Containers Recent Developments/Updates
6.2 CIBESMED Ltd
6.2.1 CIBESMED Ltd Company Information
6.2.2 CIBESMED Ltd Description and Business Overview
6.2.3 CIBESMED Ltd Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CIBESMED Ltd Infectious Substance Packaging Product Portfolio
6.2.5 CIBESMED Ltd Recent Developments/Updates
6.3 ALEX BREUER GMBH
6.3.1 ALEX BREUER GMBH Company Information
6.3.2 ALEX BREUER GMBH Description and Business Overview
6.3.3 ALEX BREUER GMBH Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ALEX BREUER GMBH Infectious Substance Packaging Product Portfolio
6.3.5 ALEX BREUER GMBH Recent Developments/Updates
6.4 E3 Cortex
6.4.1 E3 Cortex Company Information
6.4.2 E3 Cortex Description and Business Overview
6.4.3 E3 Cortex Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.4.4 E3 Cortex Infectious Substance Packaging Product Portfolio
6.4.5 E3 Cortex Recent Developments/Updates
6.5 Berlin Packaging LLC
6.5.1 Berlin Packaging LLC Company Information
6.5.2 Berlin Packaging LLC Description and Business Overview
6.5.3 Berlin Packaging LLC Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Berlin Packaging LLC Infectious Substance Packaging Product Portfolio
6.5.5 Berlin Packaging LLC Recent Developments/Updates
6.6 CFT Canada
6.6.1 CFT Canada Company Information
6.6.2 CFT Canada Description and Business Overview
6.6.3 CFT Canada Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CFT Canada Infectious Substance Packaging Product Portfolio
6.6.5 CFT Canada Recent Developments/Updates
6.7 ICC
6.7.1 ICC Company Information
6.7.2 ICC Description and Business Overview
6.7.3 ICC Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ICC Infectious Substance Packaging Product Portfolio
6.7.5 ICC Recent Developments/Updates
6.8 Therapak™
6.8.1 Therapak™ Company Information
6.8.2 Therapak™ Description and Business Overview
6.8.3 Therapak™ Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Therapak™ Infectious Substance Packaging Product Portfolio
6.8.5 Therapak™ Recent Developments/Updates
6.9 Serpac
6.9.1 Serpac Company Information
6.9.2 Serpac Description and Business Overview
6.9.3 Serpac Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Serpac Infectious Substance Packaging Product Portfolio
6.9.5 Serpac Recent Developments/Updates
6.10 Friobox
6.10.1 Friobox Company Information
6.10.2 Friobox Description and Business Overview
6.10.3 Friobox Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Friobox Infectious Substance Packaging Product Portfolio
6.10.5 Friobox Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infectious Substance Packaging Industry Chain Analysis
7.2 Infectious Substance Packaging Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infectious Substance Packaging Production Mode & Process Analysis
7.4 Infectious Substance Packaging Sales and Marketing
7.4.1 Infectious Substance Packaging Sales Channels
7.4.2 Infectious Substance Packaging Distributors
7.5 Infectious Substance Packaging Customer Analysis
8 Infectious Substance Packaging Market Dynamics
8.1 Infectious Substance Packaging Industry Trends
8.2 Infectious Substance Packaging Market Drivers
8.3 Infectious Substance Packaging Market Challenges
8.4 Infectious Substance Packaging Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Infectious Substance Packaging Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Infectious Substance Packaging Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Infectious Substance Packaging Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Infectious Substance Packaging Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Infectious Substance Packaging Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Infectious Substance Packaging Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Infectious Substance Packaging Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Infectious Substance Packaging Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Infectious Substance Packaging, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Infectious Substance Packaging, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Infectious Substance Packaging, Product Type & Application
 Table 12. Global Key Manufacturers of Infectious Substance Packaging, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Infectious Substance Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Substance Packaging as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Infectious Substance Packaging Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Infectious Substance Packaging Sales by Region (2020-2025) & (K Units)
 Table 18. Global Infectious Substance Packaging Sales Market Share by Region (2020-2025)
 Table 19. Global Infectious Substance Packaging Sales by Region (2026-2031) & (K Units)
 Table 20. Global Infectious Substance Packaging Sales Market Share by Region (2026-2031)
 Table 21. Global Infectious Substance Packaging Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Infectious Substance Packaging Revenue Market Share by Region (2020-2025)
 Table 23. Global Infectious Substance Packaging Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Infectious Substance Packaging Revenue Market Share by Region (2026-2031)
 Table 25. North America Infectious Substance Packaging Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Infectious Substance Packaging Sales by Country (2020-2025) & (K Units)
 Table 27. North America Infectious Substance Packaging Sales by Country (2026-2031) & (K Units)
 Table 28. North America Infectious Substance Packaging Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Infectious Substance Packaging Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Infectious Substance Packaging Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Infectious Substance Packaging Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Infectious Substance Packaging Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Infectious Substance Packaging Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Infectious Substance Packaging Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Infectious Substance Packaging Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Infectious Substance Packaging Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Infectious Substance Packaging Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Infectious Substance Packaging Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Infectious Substance Packaging Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Infectious Substance Packaging Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Infectious Substance Packaging Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Infectious Substance Packaging Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Infectious Substance Packaging Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Infectious Substance Packaging Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Infectious Substance Packaging Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Infectious Substance Packaging Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Infectious Substance Packaging Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Infectious Substance Packaging Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Infectious Substance Packaging Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Infectious Substance Packaging Sales (K Units) by Type (2020-2025)
 Table 51. Global Infectious Substance Packaging Sales (K Units) by Type (2026-2031)
 Table 52. Global Infectious Substance Packaging Sales Market Share by Type (2020-2025)
 Table 53. Global Infectious Substance Packaging Sales Market Share by Type (2026-2031)
 Table 54. Global Infectious Substance Packaging Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Infectious Substance Packaging Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Infectious Substance Packaging Revenue Market Share by Type (2020-2025)
 Table 57. Global Infectious Substance Packaging Revenue Market Share by Type (2026-2031)
 Table 58. Global Infectious Substance Packaging Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Infectious Substance Packaging Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Infectious Substance Packaging Sales (K Units) by Application (2020-2025)
 Table 61. Global Infectious Substance Packaging Sales (K Units) by Application (2026-2031)
 Table 62. Global Infectious Substance Packaging Sales Market Share by Application (2020-2025)
 Table 63. Global Infectious Substance Packaging Sales Market Share by Application (2026-2031)
 Table 64. Global Infectious Substance Packaging Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Infectious Substance Packaging Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Infectious Substance Packaging Revenue Market Share by Application (2020-2025)
 Table 67. Global Infectious Substance Packaging Revenue Market Share by Application (2026-2031)
 Table 68. Global Infectious Substance Packaging Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Infectious Substance Packaging Price (US$/Unit) by Application (2026-2031)
 Table 70. Air Sea Containers Company Information
 Table 71. Air Sea Containers Description and Business Overview
 Table 72. Air Sea Containers Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Air Sea Containers Infectious Substance Packaging Product
 Table 74. Air Sea Containers Recent Developments/Updates
 Table 75. CIBESMED Ltd Company Information
 Table 76. CIBESMED Ltd Description and Business Overview
 Table 77. CIBESMED Ltd Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CIBESMED Ltd Infectious Substance Packaging Product
 Table 79. CIBESMED Ltd Recent Developments/Updates
 Table 80. ALEX BREUER GMBH Company Information
 Table 81. ALEX BREUER GMBH Description and Business Overview
 Table 82. ALEX BREUER GMBH Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. ALEX BREUER GMBH Infectious Substance Packaging Product
 Table 84. ALEX BREUER GMBH Recent Developments/Updates
 Table 85. E3 Cortex Company Information
 Table 86. E3 Cortex Description and Business Overview
 Table 87. E3 Cortex Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. E3 Cortex Infectious Substance Packaging Product
 Table 89. E3 Cortex Recent Developments/Updates
 Table 90. Berlin Packaging LLC Company Information
 Table 91. Berlin Packaging LLC Description and Business Overview
 Table 92. Berlin Packaging LLC Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Berlin Packaging LLC Infectious Substance Packaging Product
 Table 94. Berlin Packaging LLC Recent Developments/Updates
 Table 95. CFT Canada Company Information
 Table 96. CFT Canada Description and Business Overview
 Table 97. CFT Canada Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CFT Canada Infectious Substance Packaging Product
 Table 99. CFT Canada Recent Developments/Updates
 Table 100. ICC Company Information
 Table 101. ICC Description and Business Overview
 Table 102. ICC Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. ICC Infectious Substance Packaging Product
 Table 104. ICC Recent Developments/Updates
 Table 105. Therapak™ Company Information
 Table 106. Therapak™ Description and Business Overview
 Table 107. Therapak™ Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Therapak™ Infectious Substance Packaging Product
 Table 109. Therapak™ Recent Developments/Updates
 Table 110. Serpac Company Information
 Table 111. Serpac Description and Business Overview
 Table 112. Serpac Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Serpac Infectious Substance Packaging Product
 Table 114. Serpac Recent Developments/Updates
 Table 115. Friobox Company Information
 Table 116. Friobox Description and Business Overview
 Table 117. Friobox Infectious Substance Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Friobox Infectious Substance Packaging Product
 Table 119. Friobox Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Infectious Substance Packaging Distributors List
 Table 123. Infectious Substance Packaging Customers List
 Table 124. Infectious Substance Packaging Market Trends
 Table 125. Infectious Substance Packaging Market Drivers
 Table 126. Infectious Substance Packaging Market Challenges
 Table 127. Infectious Substance Packaging Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Infectious Substance Packaging
 Figure 2. Global Infectious Substance Packaging Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Substance Packaging Market Share by Type: 2024 & 2031
 Figure 4. UN2814 Product Picture
 Figure 5. UN2900 Product Picture
 Figure 6. UN3373 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Infectious Substance Packaging Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Infectious Substance Packaging Market Share by Application: 2024 & 2031
 Figure 10. Healthcare and Medical Laboratories
 Figure 11. Pharmaceutical Industry
 Figure 12. Veterinary Medicine
 Figure 13. Hazardous Waste Management
 Figure 14. Global Infectious Substance Packaging Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Infectious Substance Packaging Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Infectious Substance Packaging Sales (2020-2031) & (K Units)
 Figure 17. Global Infectious Substance Packaging Average Price (US$/Unit) & (2020-2031)
 Figure 18. Infectious Substance Packaging Report Years Considered
 Figure 19. Infectious Substance Packaging Sales Share by Manufacturers in 2024
 Figure 20. Global Infectious Substance Packaging Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Infectious Substance Packaging Players: Market Share by Revenue in Infectious Substance Packaging in 2024
 Figure 22. Infectious Substance Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Infectious Substance Packaging Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Infectious Substance Packaging Sales Market Share by Country (2020-2031)
 Figure 25. North America Infectious Substance Packaging Revenue Market Share by Country (2020-2031)
 Figure 26. United States Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Infectious Substance Packaging Sales Market Share by Country (2020-2031)
 Figure 29. Europe Infectious Substance Packaging Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Infectious Substance Packaging Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Infectious Substance Packaging Revenue Market Share by Region (2020-2031)
 Figure 37. China Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Infectious Substance Packaging Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Infectious Substance Packaging Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Infectious Substance Packaging Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Infectious Substance Packaging Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Infectious Substance Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Infectious Substance Packaging by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Infectious Substance Packaging by Type (2020-2031)
 Figure 56. Global Infectious Substance Packaging Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Infectious Substance Packaging by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Infectious Substance Packaging by Application (2020-2031)
 Figure 59. Global Infectious Substance Packaging Price (US$/Unit) by Application (2020-2031)
 Figure 60. Infectious Substance Packaging Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Premade Pouch Packaging Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16J6117
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Corrugated Packaging Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27N5832
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Green Packaging Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35D5889
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Highly Visible Packaging Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17V6172
Fri Sep 12 00:00:00 UTC 2025

Add to Cart